NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
59 hedge funds and large institutions have $533M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
59
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$30.6M | |
| 2 | +$5.33M | |
| 3 | +$5.23M | |
| 4 |
PS
Peter Svennilson
|
+$4.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.56M |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$5.04M | |
| 3 | -$4.39M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.99M |
| 5 |
JRP
Jasper Ridge Partners
Menlo Park,
California
|
-$795K |